Back
Regenxbio 10K Form
Sell
21
RGNX
Regenxbio
Last Price:
9.21
Seasonality Move:
-5.66%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
| 2023-11-08 | 10Q | RGNX/Regenxbio Quarterly |
| 2023-08-02 | 10Q | RGNX/Regenxbio Quarterly |
| 2023-05-03 | 10Q | RGNX/Regenxbio Quarterly |
| 2022-11-03 | 10Q | RGNX/Regenxbio Quarterly |
| 2022-08-03 | 10Q | RGNX/Regenxbio Quarterly |
| 2022-05-04 | 10Q | RGNX/Regenxbio Quarterly |
Receive RGNX News And Ratings
See the #1 stock for the next 7 days that we like better than RGNX
RGNX Financial Statistics
Sales & Book Value
| Annual Sales: | $90.24M |
|---|---|
| Cash Flow: | $-40.88M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $6.09 |
| Price / Book: | 1.67 |
Profitability
| EPS (TTM): | -5.02000 |
|---|---|
| Net Income (TTM): | $-238.81M |
| Gross Margin: | $53.03M |
| Return on Equity: | -69.62% |
| Return on Assets: | -40.82% |
Regenxbio Earnings Forecast
Key Regenxbio Financial Ratios
- The Gross Profit Margin over the past 11 years for RGNX is 58.76%.
- The Selling, General & Administrative Expenses for RGNX have been equal to 98.06% of Gross Profit Margin.
- The Research & Development expenses have been 257.38% of Revenue.
- The Interest Expense is -2.60% of Operating Income.
- The Net Earning history of RGNX is -291.99% of Total Revenues.
- Per Share Earnings over the last 11 years have been positive in 5 years.
Regenxbio Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | RGNX |
| CUSIP: | 75901B |
| Website: | regenxbio.com |
Debt
| Debt-to-Equity Ratio: | 0 |
|---|---|
| Current Ratio: | 3.05 |
| Quick Ratio: | 2.73 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |